- Home
- ICON vs CPHI Comparison
ICON vs CPHI Comparison
Compare ICON & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- CPHI
- Stock Information
- Founded
- ICON 2023
- CPHI N/A
- Country
- ICON Greece
- CPHI China
- Employees
- ICON N/A
- CPHI N/A
- Industry
- ICON
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- ICON
- CPHI Health Care
- Exchange
- ICON Nasdaq
- CPHI Nasdaq
- Market Cap
- ICON 4.7M
- CPHI 4.7M
- IPO Year
- ICON 2024
- CPHI N/A
- Fundamental
- Price
- ICON $2.07
- CPHI N/A
- Analyst Decision
- ICON Strong Buy
- CPHI
- Analyst Count
- ICON 1
- CPHI 0
- Target Price
- ICON $4.50
- CPHI N/A
- AVG Volume (30 Days)
- ICON 34.3K
- CPHI 21.9K
- Earning Date
- ICON 09-10-2025
- CPHI 11-12-2025
- Dividend Yield
- ICON 454.11%
- CPHI N/A
- EPS Growth
- ICON N/A
- CPHI N/A
- EPS
- ICON N/A
- CPHI N/A
- Revenue
- ICON $6,137,000.00
- CPHI $4,396,201.00
- Revenue This Year
- ICON $94.05
- CPHI N/A
- Revenue Next Year
- ICON $18.81
- CPHI N/A
- P/E Ratio
- ICON N/A
- CPHI N/A
- Revenue Growth
- ICON 25.60
- CPHI N/A
- 52 Week Low
- ICON $1.60
- CPHI $1.20
- 52 Week High
- ICON $130.80
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- ICON 44.28
- CPHI N/A
- Support Level
- ICON $2.00
- CPHI N/A
- Resistance Level
- ICON $2.11
- CPHI N/A
- Average True Range (ATR)
- ICON 0.10
- CPHI 0.00
- MACD
- ICON -0.00
- CPHI 0.00
- Stochastic Oscillator
- ICON 14.71
- CPHI 0.00
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.